• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES US SAPIEN 3 ULTRA VALVE, 23MM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES US SAPIEN 3 ULTRA VALVE, 23MM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750TFX23A
Device Problem Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/14/2022
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.
 
Event Description
Per pre-deco findings revealed a sheath puncture resulting in a minor bent strut observed on the inflow side of valve.As reported by the edwards field clinical specialist, during implant of a 23mm sapien 3 ultra valve in the aortic position, the first valve and delivery system was wasted due to the inability to advance through the iliac stent in the working side.During removal of the delivery system with valve, the valve was pulled off the delivery system and got stuck in the sheath.The sheath was removed.A second sheath was advanced into the working side and the iliac stent had to be ballooned to a larger diameter with an 8mm peripheral balloon.The second delivery system with valve was able to be advanced and deployed without complication.The 23mm sapien 3 ultra valve was successfully deployed.
 
Manufacturer Narrative
Update to h6 (component code, type of investigation, investigation findings, and investigation conclusion), and h10 to reflect device evaluation.The 23mm sapien 3 ultra valve was returned to edwards for evaluation.Visual inspection revealed crimped thv stuck inside the sheath housing, minor bent strut at the inflow and outflow side.After the valve was expanded visual inspection revealed no bent struts, frame distorted/canted, and leaflets were wrinkled and dehydrated due to storage condition (prolonged crimping) during the return handling process.A device history record (dhr) review was performed and did not reveal any manufacturing non-conformances that would have contributed to the complaint event.A lot history review was performed and did not reveal any other complaints related to this event.The commander with s3/s3u/s3ur ifu and procedural training manual commander with s3u was reviewed for instructions and guidance.The procedural training manual provides guidance on delivery system removal.Completely unflex the delivery system, ensure the flex tip is still over the triple marker, ensure balloon lock is locked, ensure the balloon is completely deflated, retract loader (if needed), pull the entire delivery system through the sheath, and maintain guidewire position in the aorta.In addition, patient injury could occur if the delivery system is not completely unflexed prior to removal.No ifu/training deficiencies were identified.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaint for frame damage was confirmed based on returned device.A review of the dhr and lot history did not provide any indication that a manufacturing non-conformance contributed to the complaint event.A review of ifu/training materials revealed no deficiencies.As reported, 'during implant of a 23mm sapien 3 ultra valve in the aortic position, the first valve and delivery system was wasted due to the inability to advance through the iliac stent in the working side.' per training manual, 'push force can vary due to angle of insertion, thv size, vessel diameter, tortuosity and degree of calcification', 'if push force is high, consider slightly pulling back the sheath 1-2 cm while advancing the thv/delivery system', and 'do not over-manipulate the sheath at any time'.Based on the complaint description patient had iliac stent.Pre-existing stent caused vessel to have undersized vessel.The presence of undersized vessel can create challenging pathway during delivery system advancement, leading to resistance.In this case, it is possible difficulty was encountered during delivery system advancement so additional manipulation was applied to overcome the resistance.So, if excessive force is applied to manipulate the device, it can lead to the valve struts interacting the sheath shaft and resulted in the valve stuck inside the housing and strut damage at the inflow.In additional, based on the description 'during removal of the delivery system with valve, the valve was pulled off the delivery system and got stuck in the sheath'.Excessive force during withdrawal may cause strut damage observed at the outflow.In this case, available information suggests that patient factors (undersized vessels) and/or procedural factors (excessive device manipulation, high push force, withdraw of crimped thv) may have contributed to the complaint event.However, a conclusive root cause was unable to be determined.Control limits are managed and assessed through complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No ifu/labeling/training manual inadequacies were identified.A product risk assessment and capa was previously initiated to investigate the cause and assess the risk associated with insertion of commander delivery system with s3u through the esheath+ resulting in frame damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
US SAPIEN 3 ULTRA VALVE, 23MM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16388650
MDR Text Key309888959
Report Number2015691-2023-10870
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103201321
UDI-Public(01)00690103201321(17)250807
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/16/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750TFX23A
Device Catalogue Number9750TFX23A
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/28/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-